CLINICAL_TRIALS
withdrawal
· 2016-01-13
Clinical Trial Update: Results From a 24 Week Trial of EMDR Combined With Venlafaxine XR [Phase 4]
Summary
A Phase 4 trial evaluating EMDR combined with venlafaxine XR for posttraumatic stress disorder was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayne-Jones Army Community Hospital | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: WITHDRAWN